(Circulation. 2004;110:II-133 II-138.)
© 2004 American Heart Association, Inc.
Surgery for Congenital Heart Disease |
From Divisions of Cardiovascular Surgery (N.C.D.O., D.A.A., H.M.B., W.G.W., G.S.V.A.) and Cardiology (F.K., I.T.A., H.M.H.), Hospital for Sick Children and University of Toronto, Toronto, Ontario, Canada.
Correspondence to Glen S. Van Arsdell, MD, Division of Cardiovascular Surgery, Hospital for Sick Children, 555 University Avenue, Toronto, Ontario, Canada M5G 1X8. E-mail glen.vanarsdell{at}sickkids.ca
| Abstract |
|---|
|
|
|---|
Methods and Results We studied 105 consecutive neonates who underwent a Norwood operation in our institution. Our treatment protocol has changed in the past 3 years to include the use of alpha-blockade with phenoxybenzamine (POB) for systemic afterload reduction and selective cerebral perfusion. Forty-eight infants had selective cerebral perfusion. Forty-two infants received POB. Sixty patients had hypoplastic left heart syndrome. There was no difference in age, diagnosis, number of neonates with weight <2.5 kg, aortic size diameter <2 mm, highest preoperative lactate level, and shunt size indexed to body weight among patients with or without use of POB. Twenty-five infants had circulatory collapse during the first 72 hours. Twelve of them could be explained by technical issues. Thirteen others who appeared clinically stable had early sudden circulatory collapse without an apparent cause. Sixteen out of 25 neonates died. Of those with technical problems, 8 out of 12 died. Based on the hazard function, 3 incremental risk factors for early circulatory collapse were technical issue at operation (P<0.001), longer cross-clamp time (P<0.007), and no use of POB (P<0.002). For a technically successful operation, freedom from circulatory collapse at 72 hours is 95% with the use of POB versus 69% without (P<0.002). Diagnosis, aortic size, atrioventricular valve function, birth weight, age at operation, and total circulatory arrest time and were not predictive of early sudden circulatory collapse.
Conclusion Recent changes in our treatment protocol have resulted in a decrease incidence of sudden circulatory collapse after the Norwood operation. Optimal surgical technique is the most important predictor of early survival. The use of aggressive afterload reduction with POB reduced the risk of early sudden arrest.
Key Words: sudden death congenital heart defects risk factors
| Introduction |
|---|
|
|
|---|
Alpha blockade with phenoxybenzamine (POB) has been used in the postoperative management after the Norwood operation. The principle of this approach is the increase in systemic cardiac output by maximal dilatation of the systemic circulation.79 This effect results in a more stable parallel circulation through prevention of fluctuations in systemic vascular resistance in the early postoperative period.9 We have incorporated this approach in our postoperative management protocol10 and have observed a decrease in sudden cardiac collapse. The current study examines early outcomes after the Norwood operation in our unit in an attempt to identify variables that may have altered the risk of unexpected circulatory collapse.
| Methods |
|---|
|
|
|---|
Morphological Characteristics
Diagnosis and morphology were established by echocardiography. Classic hypoplastic left heart syndrome was present in 60 infants: aortic stenosis/mitral stenosis, n=22 (37%); aortic stenosis/mitral atresia, n =20 (33%); aortic atresia/mitral stenosis, n=10 (17%); and aortic atresia/mitral atresia, n=8 (13%). Non hypoplastic left heart syndrome diagnoses included unbalanced atrioventricular septal defect (n=11), double outlet right ventricle (n=8), double inlet left ventricle (n=8), tricuspid atresia with transposed great vessels (n=5), and other (n=13).
Mean ascending aortic diameter was 4.5±2.0 mm (range, 1.2 to 9.6 mm). Atrioventricular (AV) valve function was normal in 69 infants. AV valve regurgitation was present in 36 infants (mild, n=33; moderate, n =3). An aberrant right subclavian artery was present in 5 infants.
Clinical Management
From January 1996 to July 1999, we used conventional postoperative management. After July 1999, we used alpha blockade and more intensive perioperative monitoring. Further description is provided.
Operative Technique
Our surgical technique has been described elsewhere.3 Since 1999, we have used low-flow cardiopulmonary bypass (CPB) and selective cerebral perfusion to limit hypothermic circulatory arrest time. CPB is established by cannulation of the proximal end of a Gore-Tex conduit used for the right modified Blalock-Taussig shunt as described by Pigula et al.11 The aortic arch is reconstructed with a homograft patch. The right modified Blalock-Taussig shunt is completed with anastomosis of the proximal conduit to the central pulmonary artery.
For the overall cohort, mean circulatory arrest time and mean aortic cross clamp time were 31±22 and 55±19 minutes, respectively. The mean selective cerebral perfusion time was 50±17 minutes (n=48). Circulatory arrest time for patients undergoing selective cerebral perfusion was 9±13 versus 50±18 for patients who had circulatory arrest used as a primary strategy (P<0.001). For patients undergoing selective cerebral perfusion the aortic cross-clamp time was longer, 66±34 versus 50±18 (P=0.004). Shunt diameter was 3.5 mm (n=88), 3.0 mm (n=14), or 4.0 mm (n=3). There was no difference in age, diagnosis, number of neonates with weight <2.5 kg, aortic size diameter <2 mm, highest preoperative lactate level, and shunt size indexed to body weight among patients with or without use of POB.
Traditional Postoperative Management (January 1996 to July 1999)
Inotropic support was initiated at the time of weaning from CPB. Usual agents were milrinone (0.66 to 0.99 µg/kg per minute), dopamine (5 µg/kg per minute), and epinephrine (0.01 µg/kg per minute). Management of Qp:Qs was based primarily on adjustments of mechanical ventilation to maintain arterial oxygen saturations of 70% to 80%, arterial pCO2 of 40 to 50 mmHg, and arterial pH of 7.35 to 7.4. When necessary, hypercarbia or nitrogen was used in combination with traditional ventilatory measures to control oxygen saturations. If needed, sodium nitroprusside was used for afterload reduction.
Current Postoperative Management (July 1999 to June 2002)
Our current strategy is to generate a balanced circulation by reduction of systemic vascular resistance and optimization of cardiac output with the use of alpha blockade.10 POB (0.25 mg/kg) is given at initiation of cardiopulmonary bypass. Before termination of bypass, milrinone (100 µg/kg) and dopamine (5 µg/kg per minute) are administered. Dopamine is generally stopped in the intensive care unit to decrease the heart rate. POB (0.5 to 1 mg/kg per 24 hours) and milrinone (0.66 to 0.99 µg/kg per minute) are maintained. Optimally, a mean arterial pressure of 40 to 45 is achieved with systolic pressure in the range of 55 to 65 and a heart rate in the range of 140 to 150 bpm. Management is guided by mixed venous oxygen saturation (SvO2) measurements from superior vena cava samples. Frequently, SvO2 is continuously monitored using an oximetric superior vena cava catheter. Adequate systemic oxygen delivery is indicated by maintaining SVO2 >45% and an arterial venous O2 difference of <30. Excessive vasodilation caused by POB is managed with vasopressin.12 Pharmacologic paralysis is maintained throughout the first 24 to 48 hours. Delayed sternal closure is used in most patients with closure when tissue edema subsides, usually postoperative day 3 to 5. Placement of a peritoneal drain is part of our routine management.
Data Acquisition and Analysis
The study was approved by the Institutional Review Board of the Hospital for Sick Children. Medical records and the surgical database were reviewed for demographic, operative and perioperative, and outcome data. Diagnosis and morphological characteristics were obtained by echocardiography.
Definitions
Early circulatory collapse was defined as either failure to come off CPB, resulting in extracorporeal membrane oxygenation (ECMO) support or death, or any case of sudden circulatory collapse requiring cardiopulmonary resuscitation and/or institution of ECMO support during the initial 72 hours. Typically, the infant appeared clinically stable and had circulatory collapse for no apparent reason or during minimal stimulation such as suctioning. A technical issue was defined as sudden circulatory collapse in which the cause was attributed to mechanical or technical problems. Coronary ischemia, shunt thrombosis, arch gradient requiring reoperation, and failed biventricular repairs are included in this definition.
Data Analysis
Goals of this analysis include defining the time-related prevalence of and risk factors for early circulatory collapse after the Norwood operation. All analyses were performed using SAS statistical software (version 8; SAS Institute, Inc). Data are described as frequency with percentage, median with range, or mean±SD as appropriate.
Time to early circulatory collapse was analyzed. Nonrisk-adjusted nonparametric estimates of time-related freedom from early circulatory collapse were plotted as KaplanMeier curves. Modeling the instantaneous risk (or hazard function), searching for multiple phases of hazard, and generation of the characteristic equation of the overall hazard function allowed computation of parametric estimates of freedom from early circulatory collapse.13
Risk factors for early circulatory collapse were sought by multivariable analysis of the parametric model with each variable noted in Table 1. Variables associated with
5 events were eliminated from consideration to minimize model overdetermination. Variable selection was by bootstrap bagging; 500 bootstrap data sets of same size as the original data set were analyzed by automated stepwise regression with entry criterion of P
0.1 and selection criterion of P
0.05. Variables occurring in 50% or more of analyses were entered into the final model and retained when P
0.05. Solution of the multivariable model allowed demonstration of the magnitude of effect of selected variables on predicted outcomes.
|
| Results |
|---|
|
|
|---|
|
Risk Factors for Early Circulatory Collapse
Three independent risk factors for early circulatory arrest were identified (Table 2). Technical issue at operation and longer cross-clamp time were associated with increased risk, whereas use of POB was associated with decreased risk.
|
The impact of POB administration for a technically successful operation is shown in Figure 2. Predicted freedom from early circulatory collapse at 72 hours is 95% with the use of POB compared with 69% without (P
0.002).
|
Figure 3 illustrates the impact of technical failure on freedom from arrest during the first 72 hours after the Norwood operation. Technical failure with or without the use of POB was associated with dismal prognosis.
|
Causes of Early Circulatory Collapse
Twelve events (11%) were explained by technical problems (see technical failures section). Thirteen (12%) patients who appeared clinically stable after the operation had unexpected early circulatory collapse. There was no apparent cause or it was in association with the trauma of suctioning the airway or other subtle event that affect either pulmonary or systemic resistance. Sixteen out of the 25 circulatory collapse infants died.
Outcome of Infants After Early Circulatory Collapse not Related to Technical Failure (n=13)
Six neonates could not be resuscitated and died. Two others were initially successfully resuscitated but died (postoperative day 8 and day 19) from sepsis. Two neonates were placed on ECMO, one survived to hospital discharge and the other died. Four infants survived to hospital discharge, including the one who required ECMO for 36 hours. Table 3 shows the time of early arrest and outcome of infants who had early circulatory collapse unrelated to technical failure.
|
Outcomes of Infants After Early Circulatory Collapse Related to Technical Failures (n=12)
Twelve neonates had early circulatory collapse that was attributed to technical problems. Eight neonates died, and 4 neonates survived to hospital discharge. Table 4 shows type of technical failure and respective outcomes.
|
Four neonates had coronary ischemia. Two required ventricular assist device support for acute right ventricular failure caused by coronary obstruction. Both survived, one after successful surgical revision of the proximal arch anastomosis and one after heart transplantation (after a failed bypass graft to the posterior descending coronary artery and failure to wean from ventricular assist device). Two other neonates died of coronary ischemia; one had a documented right coronary arterial thrombus and infarct on autopsy and one died in the operating room from acute myocardial failure and ischemia.
Two neonates had aortic arch obstruction and underwent successful reoperation after initial circulatory collapse. Two other neonates failed biventricular repair before the Norwood operation. One died of sepsis after an attempted VSD closure/arch reconstruction and a Norwood operation and the other died after an attempted repair of interrupted aortic arch and VSD closure with failure to wean from bypass, ECMO support followed by an attempted Norwood operation, and death. The modified Blalock-Taussig shunt (MBTS) was the source of major complications and death in 4 patients. One died of early shunt thrombosis, 1 required early ECMO and died after revision of MBTS, and 2 others died of sepsis after initial collapse and early revisions of MBTS.
Laboratory Results
There was a trend toward lower intensive care unit admission lactate levels when selective cerebral perfusion was used (7.9±4.9 versus 6.3±3.5, P=0.08). Postoperative lactate levels clearance was not different in patients with and without use of POB (median 6 [0 to 36 hours] versus median 8 [0 to 42] P=0.3, respectively). After adjusting for the frequency of technical failures, lower SvO2 was associated with circulatory collapse (50% versus 37%, 50% versus 39%, and 53% versus 35% at 4, 12, and 24 hours, respectively) (all P<0.005).
| Discussion |
|---|
|
|
|---|
Hemodynamic stability in the early postoperative period after the Norwood palliation is dependent on an adequate cardiac output and a balanced Qp:Qs. The systemic oxygen saturation alone is a poor predictor of Qp:Qs because of variability in SvO2 and pulmonary vein saturation (SpVO2) after the Norwood operation14
Charpie et al reported on the evaluation of systemic perfusion by monitoring the oxygen delivery at tissue level using serum bicarbonate and lactate levels.15 In his study all negative events were preceded by an abrupt increase in lactate. Furthermore, all patients with good outcome returned to normal lactate level by 24 hours. He concluded that serum lactate may be a useful marker for the need for intervention in the postoperative period.15 In our study lactate levels were not a sensitive predictor of poor early outcome. The lactate level can be a relatively late sign of systemic hypoperfusion secondary to pulmonary overcirculation.
Rossi et al reported on the importance of monitoring SvO2 for assessment of cardiac output and systemic perfusion after the Norwood operation.16 More recently the use of alpha blockade has been introduced with remarkable improvement in survival after the Norwood operation.79 The alpha blockade strategy centers on the decrease of the energy requirement and oxygen consumption from the injured postoperative neonatal myocardium. It is well-established that the energy expenditure is greater when the heart is faced with increase afterload than when it is ejecting a larger volume of blood against a lower pressure. During isovolumic contraction, the energy absorbed by shape changes and elasticities in the ventricular walls is much greater when the ventricle develops pressure than when it ejects volume.17 Simply stated, pressure generation by the myocardium is energetically more costly than volume ejection. On the alpha blockade strategy, manipulation of the myocardial oxygen consumption is obtained by control of heart rate, control of preload, and mainly aggressive afterload reduction.10 POB promotes irreversible binding of alpha receptors, the serum half-life is
12 hours, and the effect may last for days because new receptors must be synthesized.
Although the infants are hemodynamically more stable, attention to detail continues to be essential. There is a risk of excessive vasodilatation causing hypotension, with high SvO2, low AVO2 difference, tachycardia, and possible signs of myocardial ischemia.10 Epinephrine infusion may exacerbate the syndrome by promoting further vasodilation via beta receptors in the presence of irreversibly blocked alpha receptors. Vasopressin seems to be the ideal drug to overcome the effects of POB under these circumstances because of selective action through a different receptor. The use of vasopressin has improved our ability to manage maximal vasodilatation safely.12
This study and others have demonstrated that the use of POB was associated with higher SvO2 reflecting a higher systemic output when compared with the traditional management. The effect of POB appears to be related to the increase SvO2 and improved end-organ perfusion.8,9
The identification of excessive pulmonary flow at the expense of systemic blood flow and associated hemodynamic decompensation has led to the use of smaller BT shunts by some groups. In a review of 122 postmortem cases, excessive pulmonary blood flow was the second most common cause of death after coronary ischemia.18 Others groups have reported that the BT shunt size was a risk factor for death.4,19 In our study, the shunt size was not a risk factor for early sudden arrest.
Twedell et al, also using an alpha blockade strategy, did not identify an independent impact of shunt size on SvO2 and delta AVO2.9 We can speculate that a larger shunt in the presence of alpha blockade strategy is not necessarily a risk factor and may be associated with better oxygen delivery overall.
Kitaichi et al in a canine model of univentricular heart demonstrated a correlation between pulmonary flow and manipulations on PaCO2 and FiO2 in a small shunt model.20 The correlation was lost in the larger shunt model. These finding strongly suggest more difficulties in regulating Qp:Qs by the traditional management in larger shunt size neonates. This difficulty may be ameliorated by the use of POB and alpha blockade.
For a patient who is systemically dilated on POB, the Qp:Qs may be insensitive to manipulation in pulmonary vascular resistance because the pulmonary shunt limits pulmonary blood flow mechanically. In other words, after a certain level, an increase in oxygen saturation causing possible increase in pulmonary flow will not cause associated decrease in SVO2 because of systemic hypoperfusion, because the MBTS act as a fixed resistor limiting the pulmonary flow after a certain level.
Although several morphological risk factors have been defined in the literature, in our study morphological subgroups and the size of the ascending aorta were not risk factors.
Limitations of the Study
Although our technique has continue to evolve and other modifications in our strategy included the use of selective cerebral perfusion, which started at approximately the same period, we believe the use of alpha blockade is the single most important variable in decreasing the incidence of sudden collapse in a neonate who had a favorable technical operation. Modifications in our perioperative care are mirrored by the improved results.
| Conclusions |
|---|
|
|
|---|
| References |
|---|
|
|
|---|
2. Iannetoni MD, Bove EL, Mosca RS, et al. Improving results with first stage palliation for hypoplastic left heart syndrome. J Thorac Cardiovasc Surg. 1994; 107: 934940.
3. Azakie A, Merklinger SL, McCrindle BW, et al. Evolving strategies and improving outcomes of the modified Norwood procedure: a 10 year single institution experience. Ann Thorac Surg. 2001; 72: 13491353.
4. Forbess JM, Cook N, Roth SJ et al. Ten-year institutional experience with palliative surgery for hypoplastic left heart syndrome- risk factors related to stage I mortality. Circulation. 1995; 92: II-262II-266.
5. Mahle WT, Spray TL, Wernosvsky G, et al. Survival after reconstructive surgery for hypoplastic left heart syndrome. A 15 year experience from a single institution. Circulation. 2000; 102: III-136III-141.
6. Ashburn DA, McCrindle BW, Tchervenkov CI, et al. Outcomes after the Norwood operation in neonates with critical aortic stenosis or aortic valve atresia. J Thorac Cardiovasc Surg. 2003; 125: 10701082.
7. Poirier NC, Jonathan JDW, Kunikazu H, et al. Modified Norwood Procedure with a high-flow cardiopulmonary bypass strategy results in low mortality without late arch obstruction. J Thorac Cardiovasc Surg. 2000; 120: 875884.
8. Tweddell JS, Hoffman GM, Mussatto KA, et al. Improved Survival of patients undergoing palliation of hypoplastic left heart syndrome: Lessons learned from 115 consecutive patients. Circulation. 2002; 106: I-82I-89.
9. Tweddell JS, Hoffman GM, Fedderly RT, et al. Phenoxybenzamine improves systemic oxygen delivery after the Norwood procedure. Ann Thorac Surg. 1999; 67: 161168.
10. De Oliveira NC, Van Arsdell GS. Practical Use of Alpha Blockade Strategy in the Management of Hypoplastic Left Heart Syndrome following Stage One Palliation with a Blalock Taussig Shunt. Pediatric Cardiac Surgery Annual. 2004: 1115.
11. Pigula FA, Nemoto EM, Griffith BP, Siewers RD. Regional low-flow perfusion provides cerebral circulatory support during neonatal aortic arch reconstruction. J Thorac Cardiovasc Surg. 2000; 119: 331339.
12. O Blenes SB, Roy N, Kostantinov I, et al. Vasopressin reversal of phenoxybenzamine induced hypotension after the Norwood procedure. J Thorac Cardiovasc Surg. 2002; 123: 10121013.
13. Blackstone EH, Naftel DC, Turner ME. The decomposition of time-varying hazard into phases, each incorporating a separate stream of concomitant information. J Am Stat Assoc. 1986; 81: 615624.[CrossRef]
14. Taeed R, Schwartz SM, Pearl JM, et al. Unrecognized Pulmonary venous desaturation early after Norwood palliation confounds Qp: Qs assessment and compromises oxygen delivery. Circulation. 2001; 103: 26992704.
15. Charpie JR, Dekeon MK, Goldberg CS, et al. Serial blood lactate measurements predict early outcome after neonatal repair or palliation for complex congenital heart disease. J Thorac Cardiovasc Surg. 2000; 120: 7380.
16. Rossi AF, Sommer RJ, Lotvin A, et al. Usefulness of intermittent monitoring of mixed venous oxygen saturation after stage I palliation for hypoplastic left heart syndrome. Am J Cardiol. 1994; 73: 11181123.[CrossRef][Medline] [Order article via Infotrieve]
17. Katz AM. The Working Heart. Physiology of the Heart. New York: Lippincott Williams & Wilkins; 2000.
18. Bartram U, Grunenfelder J, Van Praagh R. Causes of death after the modified Norwood procedure: A study of 122 postmortem cases. Ann Thorac Surg. 1997; 64: 17951802.
19. Bando K, Turrentine MW, Sun K et al. Surgical management of hypoplast left heart syndrome. Ann Thorac Surg. 1996; 62: 7077.
20. Kitaichi T, Chikugo F, Kawahito T et al. Suitable shunt size for regulation of pulmonary blood flow in a canine model of univentricular parallel circulations. J Thorac Cardiovasc Surg. 2003; 125: 7178.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2004 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |